Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLV vs GSK✓SelectedUSD · GSKXLV vs GSK performance historyLatest closeAs of-0.12%11/20
Stock and ETF performance explorer

XLV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.5%
GSK return
-4.9%
Excess return
+26.4%
Maximum drawdown
-6.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-0.1%0.0%-0.1%
7D-6.1%-5.3%-0.8%-3.5%
30D-1.0%-3.7%+2.7%+0.8%
3M+3.2%-7.3%+10.5%+7.0%
6M+21.5%-4.2%+25.7%+23.8%
All+21.5%-4.9%+26.4%+23.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling